Literature DB >> 25093081

Breast cancer in Egypt, China and Chinese: statistics and beyond.

Hamdy A Azim1, Amal S Ibrahim1.   

Abstract

Entities:  

Year:  2014        PMID： 25093081      PMCID： PMC4120163          DOI： 10.3978/j.issn.2072-1439.2014.06.38

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  Urban-rural differences in breast cancer incidence in Egypt (1999-2006).

Authors:  Subhojit Dey; Amr S Soliman; Ahmad Hablas; Ibrahim A Seifeldein; Kadry Ismail; Mohamed Ramadan; Hesham El-Hamzawy; Mark L Wilson; Mousumi Banerjee; Paolo Boffetta; Joe Harford; Sofia D Merajver
Journal:  Breast       Date:  2010-05-08       Impact factor: 4.380

Review 2.  Breast cancer statistics, 2013.

Authors:  Carol DeSantis; Jiemin Ma; Leah Bryan; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-10-01       Impact factor: 508.702

3.  Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status.

Authors:  Scarlett Lin Gomez; Thu Quach; Pamela L Horn-Ross; Jane T Pham; Myles Cockburn; Ellen T Chang; Theresa H M Keegan; Sally L Glaser; Christina A Clarke
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

4.  Cancer trends in Taiwan.

Authors:  Chun-Ju Chiang; Yong-Chen Chen; Chien-Jen Chen; San-Lin You; Mei-Shu Lai
Journal:  Jpn J Clin Oncol       Date:  2010-05-21       Impact factor: 3.019

5.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

6.  Dietary patterns and breast cancer risk in the shanghai breast cancer study.

Authors:  Xiaohui Cui; Qi Dai; Marilyn Tseng; Xiao-Ou Shu; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07-10       Impact factor: 4.254

Review 7.  Environmental pollutants and breast cancer: epidemiologic studies.

Authors:  Julia Green Brody; Kirsten B Moysich; Olivier Humblet; Kathleen R Attfield; Gregory P Beehler; Ruthann A Rudel
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

8.  Cancer incidence in the United Kingdom: projections to the year 2030.

Authors:  M Mistry; D M Parkin; A S Ahmad; P Sasieni
Journal:  Br J Cancer       Date:  2011-10-27       Impact factor: 7.640

9.  Cancer incidence in egypt: results of the national population-based cancer registry program.

Authors:  Amal S Ibrahim; Hussein M Khaled; Nabiel Nh Mikhail; Hoda Baraka; Hossam Kamel
Journal:  J Cancer Epidemiol       Date:  2014-09-21

10.  Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies.

Authors:  Meinan Chen; Yanhua Rao; Yi Zheng; Shiqing Wei; Ye Li; Tong Guo; Ping Yin
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240
View more
  17 in total

1.  Bioinformatic analysis of differential expression and core GENEs in breast cancer.

Authors:  Hongchang Dong; Shuai Zhang; Yu Wei; Chunyan Liu; Na Wang; Pan Zhang; Jingling Zhu; Jin Huang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.

Authors:  Tong Wang; Yuanyuan Ma; Liang Wang; Hong Liu; Meixuan Chen; Ruifang Niu
Journal:  Tumour Biol       Date:  2015-03-25

Review 3.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

4.  Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients.

Authors:  Ren-Wang Chen; Qiong Wang; Ting Hu; Yu-Xiu Xie; Hai-Yan Chang; Jing Cheng
Journal:  Curr Med Sci       Date:  2022-03-21

5.  Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.

Authors:  Qian Xie; Hanrui Zheng; Qiu Li
Journal:  Breast Care (Basel)       Date:  2021-09-09       Impact factor: 2.268

6.  25-methoxyl-dammarane-3β, 12β, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression.

Authors:  Danfeng Wang; Yuqing Zhao; Yimeng Wang; Yan Rong; Hongshuang Qin; Yongli Bao; Zhenbo Song; Chunlei Yu; Luguo Sun; Yuxin Li
Journal:  Tumour Biol       Date:  2016-04-02

Review 7.  Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.

Authors:  Mei Liu; Zhiyang Li; Jingjing Yang; Yanyun Jiang; Zhongsi Chen; Zeeshan Ali; Nongyue He; Zhifei Wang
Journal:  Cell Prolif       Date:  2016-06-16       Impact factor: 6.831

8.  Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes.

Authors:  Amany Samir; Reda Abdel Tawab; Hend M Eltayebi
Journal:  Oncol Lett       Date:  2021-06-07       Impact factor: 2.967

9.  Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.

Authors:  Yan Dong; Baoping Cao; Meiying Zhang; Weidong Han; James G Herman; François Fuks; Yali Zhao; Mingzhou Guo
Journal:  Oncotarget       Date:  2015-09-08

10.  Estimation of cancer burden in Guangdong Province, China in 2009.

Authors:  Su-Mei Cao; Yan-Jun Xu; Guo-Zhen Lin; Qi-Hong Huang; Kuang-Rong Wei; Shang-Hang Xie; Qing Liu
Journal:  Chin J Cancer       Date:  2015-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.